AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$1,652,427
-3.42%
Shares
Shares Volume: 84,093 Shares
Average Share Price: $19.65
INSIDER
Aziz Kabeer
Director
reported on Jan 18 2024
traded on Jan 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 2,373,500 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $247,968.24 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 2 / 35 |
| P/S VALUE RATIO | 1.933 |
| AVERAGE SALE VALUE | $237,247.18 |
| COMPANY PREVIOUS TRADES |